Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
about
Viro-immune therapy: A new strategy for treatment of pancreatic cancerOncolytic viral therapy for pancreatic cancer: current research and future directionsMeasles to the Rescue: A Review of Oncolytic Measles VirusOncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancerHigh scFv-receptor affinity does not enhance the antitumor activity of HER2-retargeted measles virus.Gene and cell therapy for pancreatic cancer.Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteinsReplication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade gliomaIn vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinomaGlobal, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.Oncolytic measles virus strains as novel anticancer agents.PRE-CLINICAL AND CLINICAL VALIDATION OF AN ANTI-CANCER MODALITY THAT ABLATES REFRACTORY, LOW GROWTH FRACTION TUMORS.In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer modelsFighting Cancer with Mathematics and Viruses.Potential and clinical translation of oncolytic measles viruses.Advances in the design and development of oncolytic measles viruses.MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.Endoscopic ultrasound in pancreatic cancer: innovative applications beyond the basics.Oncolytic viral therapy for pancreatic cancer.Modelling the spatiotemporal dynamics of chemovirotherapy cancer treatment.[Measles virus: a future therapeutic agent in oncology?].
P2860
Q26774641-2D69175A-9C81-4DBE-8BAE-CFD2D3F19C15Q27011439-FE4FF280-0343-4E2F-B524-261595C02A78Q28072097-375266B1-C0D5-45AE-B2B2-875D45F34ABAQ28078939-1820B320-A07E-4D36-9D89-D0200D200960Q33896979-BE5C3CD9-2CF1-4B9B-AECB-439426CC6535Q35541787-1FDE1081-79F6-4973-83F5-857028BD7301Q35666025-892164E8-F005-4D02-8FD5-79CAD783D0F6Q35939421-F242AF14-96F9-429F-88CA-3CEE67170154Q36176245-EFB98872-30B8-4963-8C0A-65058E8908C4Q36848730-AC36B178-B15F-4070-8E76-47800E2E1FD8Q37026797-4421D1D2-C8DB-4FEA-9B99-157FC33B7CBCQ37035678-E441FA1D-1509-4C08-8653-32F27C8DAB00Q37261017-9D7DA8E3-73FA-429A-957E-4921AD1BDFD4Q37563779-2BB85145-9A78-471D-AA43-86E3C7CDA41FQ37629550-B65573E2-6F82-4AE9-B2E3-AB2FB4E9534FQ38612646-1FC96DD4-2D29-4961-9A29-FAB96E5678BAQ38764947-BA9DE41B-D7FC-4172-8BB8-9CCBF2337E23Q38924566-0A2D1372-CD74-4B78-9EF5-0F8FDC8619F9Q38964020-8B27774B-9503-4939-B9B0-48C6598B6E9FQ39025906-B8F7C095-6C87-458B-86B5-D3DAD56BFE22Q39240683-4DB2B883-2211-42E7-AB5F-7E299BC63C17Q40188505-CC86B172-72EA-40AA-9AB0-8A81D8A5FC33Q53171426-17533880-0458-4A22-A7CB-03A548840EF8
P2860
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
@en
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
@nl
type
label
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
@en
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
@nl
prefLabel
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
@en
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer
@en
P2093
C Grossardt
C von Kalle
E P Rieber
G Ungerechts
R Cattaneo
P2860
P2888
P304
P356
10.1038/CGT.2011.30
P577
2011-06-24T00:00:00Z